pilldic.내 손안의 약 사전
글자 크기
← 미국약 목록
미국 · 일반의약품(OTC) 설명서

DRAMAMINE

제형
TABLET, CHEWABLE
업체
Medtech Products Inc.
원문 갱신
2024-10-25
가져온 날
2026-09-07
유효 성분
MECLIZINE HYDROCHLORIDE
DailyMed 원문·등록 이미지 확인 ↗
기타 원문Label information

Drug Facts

유효 성분Active ingredient (in each tablet)

Meclizine HCl 25 mg

성분·작용Purpose

Antiemetic

효능·용도Use

for prevention and treatment of these symptoms associated with motion sickness:

■nausea ■vomiting ■dizziness

주의사항Warnings

Do not give to

children under 12 years of age unless directed by a doctor

Ask a doctor before use if you have

■a breathing problem such as emphysema or chronic bronchitis

■glaucoma

■trouble urinating due to an enlarged prostate gland

Ask a doctor or pharmacist before use if you are taking

sedatives or tranquilizers

When using this product

■drowsiness may occur

■avoid alcoholic drinks

■alcohol, sedatives, and tranquilizers may increase drowsiness

■be careful when driving a motor vehicle or operating machinery

If pregnant or breast-feeding,

ask a doctor before use.

Keep out of reach of children .

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

복용법·사용법Directions

■to prevent motion sickness take first dose ½ hour to 1 hour before activity that may result in nausea

■to treat motion sickness, take at first signs of symptoms

adults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor

Other informationOther information

■store at room temperature 20°–25°C (68°-77°F)

첨가제Inactive i ngredients

croscarmellose sodium, crospovidone, FD&C red #40 lake, lactose, magnesium stearate, raspberry flavor, silica, sodium saccharin, stearic acid, vanilla flavor

제조사 문의Questions?

1-800-382-7219

포장 표시P RINCIPAL DISPLAY PANEL

All Day Less Drowsy Chewable Formula

Dramamine®

Meclizine HCl 25 mg /Motion Sickness Relief

12 Raspberry Cream Flavored Chewable Tablets (25mg EACH)

[Image in the official label — see DailyMed source]

DailyMed Set ID: f8cf751a-9f19-4744-a350-cd22303435ee · 버전 2
NDC: 63029-906